Interestingly, in patients without previously diagnosed PCa ISET-CTC-based screening demonstrated a predictive value of 99% compared to 25% with the standard PSA-based test method within patients receiving PSMA-PET-imaging later on. This evidence concerns the gene FOLH1 and posterior cortical atrophy.